Germany’s healthcare system is widely recognized as one of the most progressive in the world, particularly in its adoption of new technologies, state-funded investments in hospital IT modernization (KHZG), advances in digital health, and the rollout of mandatory electronic health records (available on a voluntary basis since 2021). With over 83 million residents, Germany is the most populous country in the European Union. Its diverse population contributes to data that reflects a wide range of genetic, social, and health backgrounds. Moreover, with approximately 90% of the population covered by public health insurance, Germany stands out for its comprehensive national healthcare coverage and robust data representation.
However, German medical data remains notoriously difficult to access due to some of the strictest data privacy laws globally, posing major barriers for innovative research efforts. As a result, researchers often turn to more easily accessible data, such as U.S. datasets. While more convenient, these datasets do not provide an accurate reflection of health trends within the German population.
In the era of personalized medicine, this gap poses a critical challenge. Relying on foreign datasets risks generating conclusions that are not applicable and actionable within the German healthcare landscape.
Since the challenge doesn’t lie in finding the data, but in accessing and securely analyzing it, the solution lies in data partnerships that enable access to German real-world datasets without raising compliance concerns. Briya is at the forefront of these partnerships, providing secure access to over 11 Million de-identified, German patient-records.
Thanks to our network of trusted healthcare partners, including the renowned Charité, we’ve built one of the most comprehensive and accessible real-world data networks in Germany. This opens the door to entirely new opportunities for conducting research with highly relevant and actionable data.
Briya’s German Real-World Data Catalogue
Powered by Briya’s advanced, end-to-end secure data access and retrieval technology – including proprietary, medically-trained large language models – our platform uniquely enables access to both structured and unstructured data sources. These include electronic health records, lab results, prescriptions, doctor’s notes, imaging data, and radiology reports.
With over 11 million records, 118 million patient-doctor interactions, 51 million diagnosis-tagged visits, and 68 million service records, our German dataset provides a highly representative and inclusive view of the population, covering more than five years of longitudinal EMRs.
The catalogue also includes a broad range of clinical modalities, such as ICD-10 diagnoses (with details on acuity, chronicity, and localization), treatment pathways, referrals, hospitalizations, sick leave records, and medication prescriptions.
By relying on a proprietary, 3-layered de-identification technology and additional privacy-ensuring features, Briya ensures full adherence to GDPR and true anonymization standards that received expert determination. Our platform is fully compliant with GDPR and German data protection laws, without compromising on essential non-identifiable patient attributes that provide valuable clinical context and classification capabilities.
Exploring Partnership Opportunities with Briya
Life sciences organizations seeking to generate real-world evidence for German market access, identify unmet needs, or conduct other observational studies can now partner with Briya to access customized, condition-specific datasets that support high-impact research initiatives.
Request your customized dataset now
To further empower researchers, data scientists, and analysts, Briya has launched the world’s first clinical-grade AI research environment: Briya AIRE. Designed to simplify and elevate medical data exploration, analysis, and insight generation, AIRE features nine purpose-built AI agents that assist at every stage of the research process. From dataset convergence and harmonization to AI-driven refinement, Briya AIRE accelerates workflows and delivers more precise, impactful research outcomes.
Related articles
Unlocking New Frontiers in Ovarian Cancer Research with Briya’s Dynamic Dataset
Affecting over 300,000 women worldwide annually, Ovaria...
Read more
The Missing Piece – Completing Medical Research with Clinical Free Text
Real world healthcare data is one of the most valuable ...
Read more
Briya Chosen as Key Contributor to Biogen HLTH Rare Disease Accelerator
Briya has been selected from among hundreds of applicat...
Read more
